ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MAKO Mako Surgical Corp. (MM)

29.99
0.00 (0.00%)
15 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Mako Surgical Corp. (MM) NASDAQ:MAKO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 29.99 0 01:00:00

MAKO Surgical Corp. Announces Appearance at the Goldman Sachs 33rd Annual Global Healthcare Conference

30/05/2012 9:05pm

GlobeNewswire Inc.


Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Mako Surgical Corp. (MM) Charts.

MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer of MAKO, will present at the Goldman Sachs 33rd Annual Global Healthcare Conference at the Terranea Resort at Ranchos Palos Verdes, CA on Tuesday, June 5, 2012 at 11:20 am PT. The presentation was originally scheduled for Thursday, June 7, 2012 at 8:40 am PT.

A webcast will be available and may be accessed by visiting MAKO's website at www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation.

About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets its RIO® Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and proprietary RESTORIS® implants for orthopedic procedures called MAKOplasty®. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables precise, consistently reproducible bone resection for the accurate insertion and alignment of MAKO's RESTORIS implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications. Additional information can be found at www.makosurgical.com.

CONTACT: Investors:
         MAKO Surgical Corp.
         Susan M. Verde
         954-628-1706
         investorrelations@makosurgical.com
         
         or
         
         Westwicke Partners
         Mark Klausner
         443-213-0500
         makosurgical@westwicke.com

1 Year Mako Surgical Corp. (MM) Chart

1 Year Mako Surgical Corp. (MM) Chart

1 Month Mako Surgical Corp. (MM) Chart

1 Month Mako Surgical Corp. (MM) Chart

Your Recent History

Delayed Upgrade Clock